Monthly Archives: July 2016

We read with great interest the study by Levenick et al1 on the utility of rectal indomethacin in consecutive patients to prevent post-ERCP pancreatitis (PEP). We congratulate the authors on their publication, but query some additional limitations tha… Continue reading →

The role of rectal nonsteroidal anti-inflammatory drugs (NSAIDs) for preventing pancreatitis in average-risk endoscopic retrograde cholangiopancreatography (ERCP) cases remains controversial. Although the European Society of Gastrointestinal Endoscopy … Continue reading →

I read with great interest the recent paper by Wernli et al1 and its accompanying editorial.2 As a practicing anesthesiologist, it is always interesting to read other specialties’ literature involving my own specialty. I believe, however, that this … Continue reading →

Studies are needed to determine the optimal regimen for patients with chronic hepatitis C virus (HCV) genotype 2, 3, 4, or 6 infections who have failed by a prior course of antiviral therapy, and the feasibility of further shortening treatment duration… Continue reading →

The best regimen to retreat patients who do not respond to direct-acting antivirals (DAAs) and the feasibility of further shortening regimens is unclear. We assessed the efficacy and safety of the combination of the nucleotide polymerase inhibitor sofo… Continue reading →

We read with great interest the article by Wernli et al1 regarding anesthesia services for colonoscopy. The authors conclude that the “overall risk of complications following colonoscopy increases when individuals receive anesthesia services.” We … Continue reading →

Question: A 49-year-old man with history of ulcerative colitis and chronic anemia presented to the emergency department with complaints of pain and swelling on his chest, rapidly increasing in size for 2–3 days. He also complained of painful swelling… Continue reading →

Colonoscopy is one of the most common screening tests for colorectal cancer worldwide.1 Despite the advance in perioperative care, colonoscopy screening still exposes patients to risk of complications and even harms. Anesthesiologists play an increasin… Continue reading →

Question: A 48-year-old man was referred to our hospital for further evaluation and treatment of recurrent abdominal pain and hematochezia. He was treated 15 years ago with interferon alpha for infection with hepatitis C virus (HCV) genotype 1; however… Continue reading →

We read with interest the recent study by Wernli et al1 describing a large retrospective analysis of >3 million patients to asses the relative risks of anesthesia services during colonoscopy. The authors correctly highlight the importance of this issue; anesthesia services are now employed in nearly 50% of cases. Although the results of the study provide us greater insights into the gastrointestinal (GI) practices across the country, we are concerned that the methodologic limitations of the study may lead some to misinterpret the findings. Continue reading →